Now not only girls, but also boys will have the opportunity to protect themselves from cancer caused by HPV.

The Ministry of Infrastructure and Water Management aims to ensure that all new materials and technological developments are safe in 2050.

The effects of the corona crisis have a greater impact on vulnerable groups in society, such as lower-educated adults, young people, the elderly and people with underlying health problems.

The vaccine against the HPV human papillomavirus virus will also become available for boys.

The European Food Safety Authority (EFSA) has published a provisional health-based guidance value for perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA).

RIVM research shows no causal link between the vaccine against cervical cancer (HPV) and long-term fatigue symptoms in girls.

The vaccination rate for vaccines included in the National Immunisation Programme has dropped slightly by about 1 percent.

In 2017, RIVM launched a Trend Scenario, as well as three thematic reports about the future demand for health care, technology and wider determinants of health.

There are a number of promising biobased alternatives to controversial polar aprotic solvents, as revealed in a report from Wageningen Food & Biobased Research commissioned by RIVM .

If historical trends continue unchanged, dementia will be the leading cause of disease burden in 2040 and the main cause of death.